Nissay Asset Management Corp Sarepta Therapeutics, Inc. Transaction History

Nissay Asset Management Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $541,233 - $676,736	-7,801 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$72.25 - $168.95 $4,262 - $9,968	-59 Reduced 0.75%	7,801 $581,000
Q4 2020 Feb 08, 2021	BUY	$125.56 - $178.74 $36,286 - $51,655	289 Added 3.82%	7,860 $1.34 Million
Q3 2020 Oct 20, 2020	BUY	$127.12 - $172.34 $26,822 - $36,363	211 Added 2.87%	7,571 $1.06 Million
Q2 2020 Jul 27, 2020	BUY	$93.0 - $171.7 $63,612 - $117,442	684 Added 10.25%	7,360 $1.18 Million
Q1 2020 May 05, 2020	BUY	$82.38 - $131.64 $20,924 - $33,436	254 Added 3.96%	6,676 $653,000
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $69,948 - $123,920	914 Added 16.59%	6,422 $829,000
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $401,037 - $864,260	5,508 New	5,508 $415,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

Stay updated on Nissay Asset Management Corp with notifications on news.